相似文献
1
Family history and APOE-4 genetic risk in Alzheimer's disease.
Neuropsychol Rev. 2012 Sep;22(3):298-309. doi: 10.1007/s11065-012-9193-2. Epub 2012 Feb 23.
2
Family history of Alzheimer's disease and hippocampal structure in healthy people.
Am J Psychiatry. 2010 Nov;167(11):1399-406. doi: 10.1176/appi.ajp.2010.09111575. Epub 2010 Aug 4.
3
Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.
Curr Alzheimer Res. 2015;12(3):218-27. doi: 10.2174/1567205012666150302160145.
4
APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.
Annu Rev Clin Psychol. 2009;5:343-62. doi: 10.1146/annurev.clinpsy.032408.153625.
5
Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention.
Metabolism. 2013 Jan;62 Suppl 1:S30-3. doi: 10.1016/j.metabol.2012.08.024. Epub 2012 Sep 26.
6
Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
Arch Neurol. 2010 Apr;67(4):462-8. doi: 10.1001/archneurol.2010.30.
7
APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.
Oncotarget. 2015 Sep 29;6(29):26663-74. doi: 10.18632/oncotarget.5185.
8
Cognitive phenotypes in Alzheimer's disease and genetic risk.
Cortex. 2007 Oct;43(7):835-45. doi: 10.1016/s0010-9452(08)70683-x.
9
An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative.
J Clin Pharmacol. 2012 May;52(5):629-44. doi: 10.1177/0091270011405497. Epub 2011 Jun 9.
10
Clinical Aspects of Alzheimer's Disease.
Adv Neurobiol. 2017;15:31-53. doi: 10.1007/978-3-319-57193-5_2.
引用本文的文献
1
Factors related to blood-based biomarkers for neurodegenerative diseases and their intergenerational associations in the Young Finns Study: a cohort study.
Lancet Healthy Longev. 2025 Jun;6(6):100717. doi: 10.1016/j.lanhl.2025.100717.
2
Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer's disease.
Brain Commun. 2025 Mar 4;7(2):fcaf099. doi: 10.1093/braincomms/fcaf099. eCollection 2025.
3
Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older 4 Carriers.
J Neurosci. 2025 Feb 5;45(6):e1408242024. doi: 10.1523/JNEUROSCI.1408-24.2024.
4
Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges.
Front Med (Lausanne). 2024 Dec 16;11:1474043. doi: 10.3389/fmed.2024.1474043. eCollection 2024.
5
Minimum spanning tree analysis of unimpaired individuals at risk of Alzheimer's disease.
Brain Commun. 2024 Aug 20;6(5):fcae283. doi: 10.1093/braincomms/fcae283. eCollection 2024.
6
APOE4-related differences in cortical thickness are modulated by sex in middle age.
Brain Imaging Behav. 2024 Oct;18(5):1163-1171. doi: 10.1007/s11682-024-00911-9. Epub 2024 Aug 28.
7
Dynamic functional connectivity is modulated by the amount of p-Tau231 in blood in cognitively intact participants.
bioRxiv. 2024 Jun 1:2024.05.29.596323. doi: 10.1101/2024.05.29.596323.
8
Subjective Cognitive Decline and Genetic Propensity for Dementia beyond Apolipoprotein ε: A Systematic Review.
Curr Issues Mol Biol. 2024 Mar 2;46(3):1975-1986. doi: 10.3390/cimb46030129.
9
Longitudinal changes in the functional connectivity of individuals at risk of Alzheimer's disease.
Geroscience. 2024 Jun;46(3):2989-3003. doi: 10.1007/s11357-023-01036-5. Epub 2024 Jan 4.
10
Therapeutic Inhalation of Hydrogen Gas for Alzheimer's Disease Patients and Subsequent Long-Term Follow-Up as a Disease-Modifying Treatment: An Open Label Pilot Study.
Pharmaceuticals (Basel). 2023 Mar 13;16(3):434. doi: 10.3390/ph16030434.
本文引用的文献
1
Brain network local interconnectivity loss in aging APOE-4 allele carriers.
Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20760-5. doi: 10.1073/pnas.1109038108. Epub 2011 Nov 21.
2
Influence of Alzheimer disease family history and genetic risk on cognitive performance in healthy middle-aged and older people.
Am J Geriatr Psychiatry. 2012 Jul;20(7):565-73. doi: 10.1097/JGP.0b013e3182107e6a.
3
Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons.
Neurobiol Aging. 2012 Apr;33(4):827.e11-9. doi: 10.1016/j.neurobiolaging.2011.06.020. Epub 2011 Aug 6.
4
The concept of FDG-PET endophenotype in Alzheimer's disease.
Neurol Sci. 2011 Aug;32(4):559-69. doi: 10.1007/s10072-011-0633-1. Epub 2011 Jun 1.
5
Interaction between vascular factors and the APOE ε4 allele in predicting rate of progression in Alzheimer's disease.
J Alzheimers Dis. 2011;26(1):127-34. doi: 10.3233/JAD-2011-110086.
6
Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease.
Neurobiol Aging. 2012 Mar;33(3):624.e1-9. doi: 10.1016/j.neurobiolaging.2011.03.003. Epub 2011 Apr 22.
7
Epigenetic mechanisms in Alzheimer's disease.
Neurobiol Aging. 2011 Jul;32(7):1161-80. doi: 10.1016/j.neurobiolaging.2010.08.017. Epub 2011 Apr 11.
8
The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations.
Int J Alzheimers Dis. 2011 Feb 24;2011:726197. doi: 10.4061/2011/726197.
9
Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.
Neurology. 2011 Mar 1;76(9):822-9. doi: 10.1212/WNL.0b013e31820e7b74.
10
Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes.
Neurology. 2011 Mar 22;76(12):1078-84. doi: 10.1212/WNL.0b013e318211c3ae. Epub 2011 Feb 16.
Zotero 插件